Swipe through the latest business and wealth clues with our android app

Dr Reddy's share price hits 52-week high post Q1 earnings

Dr Reddy's Laboratories share price touched a 52-week high of Rs 4,447.80, rising more than 3% in the morning trade on July 30, a day after the company reported a 12.6% YoY drop in consolidated net profit at Rs 579 crore for Q1FY21 compared with Rs 662.8 crore in Q1FY20. Revenue from operations during Q1FY21 stood at Rs 4,418 crore, up 15% YoY. The company continues to be one of the best companies in largecap pharma space structurally, though there is limited headroom for a further upgrade in earnings estimate and PE expansion. Motilal Oswal has kept the rating 'neutral'.

Read More at Moneycontrol News date : 30 Jul 2020, Thursday

©2020 TheNewsClues